As has been evidenced by Bai et al., CA can limit inflammatory responses by enhancing mitochondrial dysfunction and promote RA-FLS apoptosis by activating the AMPK/SIRT1/NF-κB pathway (94). The gene discussed is NFKB1; the disease is rheumatoid arthritis.